Use and Labeling of Nanomaterials in the EU

Jul 1, 2013 | Contact Author | By: Chris Flower, PhD, CTPA
Your message has been sent.
(click to close)
Contact the Author
Save
This item has been saved to your library.
View My Library
(click to close)
Save to My Library
Title: Use and Labeling of Nanomaterials in the EU
nanomaterialsx titanium dioxidex zinc oxidex Regulation EC No. 1223/2009x labelingx
  • Article
  • Media
  • Keywords/Abstract
  • Related Material

Keywords: nanomaterials | titanium dioxide | zinc oxide | Regulation EC No. 1223/2009 | labeling

Abstract: Although originally presented as a consolidation and simplification of the Cosmetics Directive and its complex amendments, the recasting of the directive into a regulation for cosmetic products was used as an opportunity to extend the scope in several areas. One of these concerned the use of nanomaterial in cosmetic products, now defined in Article 2(k) of the regulation. It states, “‘Nanomaterial’ means an insoluble or biopersistent and intentionally manufactured material with one or more external dimensions, or an internal structure, on the scale from 1 to 100 nm.”

View citation for this article

C Flower, Use and Labeling of Nanomaterials in the EU, Cosm & Toil 128(7) 448 (2013)

Market Data

  • Awareness among consumers about the harmful effects of UV boosted sun care sales by 6.5% in 2012 in the United States.
  • Sun care marketers are diversifying their product offerings; a common trend emerging is to include tint.
  • Although spray-on sun care products are popular, there are rising concerns associated with the inhalation of nanoparticles.
view full article

Excerpt Only This is a shortened version or summary of the article you requested. To view the complete article, please log in or create an account. Registration is Free!

On July 11, 2013, European Cosmetics Regulation EC No. 1223/2009 will be fully enforced across the Member States of the European Union (EU). This regulation is directly applicable and does not require national implementation, unlike the Cosmetics Directive 76/768/EEC that it replaces. As explained in the March 2013 edition of this column, the main purpose of the regulation is unchanged: to provide high level protection to human health and a single-functioning internal European market for goods and services.

Although originally presented as a consolidation and simplification of the Cosmetics Directive and its complex amendments, the recasting of the directive into a regulation for cosmetic products was used as an opportunity to extend the scope in several areas. One of these concerned the use of nanomaterial in cosmetic products, now defined in Article 2(k) of the regulation. It states, “‘Nanomaterial’ means an insoluble or biopersistent and intentionally manufactured material with one or more external dimensions, or an internal structure, on the scale from 1 to 100 nm.”

Although this definition sounds useful in the context of cosmetic ingredients, in practice, almost all of the elements need further clarification and agreement, including: insoluble, biopersistent, intentional, manufactured and internal structure. There are also difficulties for ingredient suppliers, product manufacturers and enforcement authorities in measuring materials in a consistent fashion when some of the particles have one or more dimensions, whether internal or external, on the 1 to 100 nm scale. Nevertheless, manufacturers or, more accurately, Responsible Persons (RP), are required to comply with specific requirements as laid out in Article 16 for nanomaterials and for cosmetic products containing nanomaterials. There are three nano-related requirements for industry: notification to the European Commission (EC) six months prior to placing the product on the market; safety assessment of the cosmetic product with particular attention to nanomaterials; and the labeling of ingredients that are nanomaterials.

Excerpt Only This is a shortened version or summary of the article you requested. To view the complete article, please log in or create an account. Registration is Free!

This content is adapted from an article in GCI Magazine. The original version can be found here.

Media

 

Close

Biography: Chris Flower, PhD, CTPA

Chris Flower, PhD, is director-general of the Cosmetic, Toiletry and Perfumery Association (CTPA), which he has strategically made more visible to both the media and the public. He joined the CTPA in 1996 after 25 years in the cosmetics industry in product safety and R&D. He is a chartered biologist with a Master’s of Science degree from the University of Surrey and a doctorate from the CNAA, both in toxicology and physiology/pathology. He is on the board of Cosmetics Europe and chairs several of its expert committees.

Next image >

 
 

Close

It's Free...

Register or Log in to get full access to this content

Registration includes:

  • Access to all premium content
  • One click ingredient sample requests
  • Save articles in the My Library tool

Create an Account or Log In